A Study of Capecitabine Versus S-1 as Adjuvant Therapy in Patients With Biliary Tract Carcinoma After Surgical Resection

Clinical trial NCT04856761 · UNKNOWN

Trial details

NCT number: NCT04856761
Sponsor: Fudan University
Status: UNKNOWN
Study type: OBSERVATIONAL

Biliary Tract Neoplasms Recurrence Cholangiocarcinoma Gall Bladder Cancer

Start date: 2020-11-01
Primary completion: 2022-12-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.